These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 3001842

  • 1. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
    Wood CL, O'Dorisio MS, Vassalo LM, Malarkey WB, O'Dorisio TM.
    Regul Pept; 1985 Nov 07; 12(3):237-48. PubMed ID: 3001842
    [Abstract] [Full Text] [Related]

  • 2. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS, Wood CL, Wenger GD, Vassalo LM.
    J Immunol; 1985 Jun 07; 134(6):4078-86. PubMed ID: 2985703
    [Abstract] [Full Text] [Related]

  • 3. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Jun 07; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 4. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 07; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 5. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE, Wood CL, O'Dorisio MS, Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1987 Mar 07; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
    Schäfer H, Schwarzhoff R, Creutzfeldt W, Schmidt WE.
    Eur J Biochem; 1991 Dec 18; 202(3):951-8. PubMed ID: 1662620
    [Abstract] [Full Text] [Related]

  • 7. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V, Farjaudon N, Bawab W, Chastre E, Rosselin G, Guilloteau P, Gespach C.
    Am J Physiol; 1991 Feb 18; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M.
    Am J Physiol; 1993 Feb 18; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [Abstract] [Full Text] [Related]

  • 9. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G, Martin JM, Luis J, el Battari A, Muller JM, Marvaldi J, Pichon J.
    Biochimie; 1988 May 18; 70(5):663-71. PubMed ID: 2844304
    [Abstract] [Full Text] [Related]

  • 10. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P, Coy DH, De Neef P, Camus JC, Cauvin A, Waelbroeck M, Christophe J.
    Eur J Biochem; 1987 Jun 01; 165(2):243-9. PubMed ID: 3036504
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Bjøro T, Ostberg BC, Sand O, Gordeladze J, Iversen JG, Torjesen PA, Gautvik KM, Haug E.
    Mol Cell Endocrinol; 1987 Feb 01; 49(2-3):119-28. PubMed ID: 2435588
    [Abstract] [Full Text] [Related]

  • 12. Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro.
    Dufes C, Alleaume C, Montoni A, Olivier JC, Muller JM.
    J Mol Neurosci; 2003 Feb 01; 21(2):91-102. PubMed ID: 14593209
    [Abstract] [Full Text] [Related]

  • 13. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
    Christophe J, Waelbroeck M, Chatelain P, Robberecht P.
    Peptides; 1984 Feb 01; 5(2):341-53. PubMed ID: 6089134
    [Abstract] [Full Text] [Related]

  • 14. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A, Rousset M, Laburthe M.
    Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337
    [Abstract] [Full Text] [Related]

  • 15. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
    Huang M, Rorstad OP.
    J Neurochem; 1984 Sep 01; 43(3):849-56. PubMed ID: 6086840
    [Abstract] [Full Text] [Related]

  • 16. The gastrin-releasing peptide receptor is differentially coupled to adenylate cyclase and phospholipase C in different tissues.
    Garcia LJ, Pradhan TK, Weber HC, Moody TW, Jensen RT.
    Biochim Biophys Acta; 1997 May 27; 1356(3):343-54. PubMed ID: 9194577
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V, Kienlen-Campard P, Loeffler JP, Basille M, Gonzalez BJ, Vaudry H, Robberecht P, Pévet P.
    Neuroscience; 1998 Aug 27; 85(3):887-96. PubMed ID: 9639281
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
    Wessels-Reiker M, Basiboina R, Howlett AC, Strong R.
    J Neurochem; 1993 Mar 27; 60(3):1018-29. PubMed ID: 8094740
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H.
    Endocrinology; 1997 May 27; 138(5):1930-4. PubMed ID: 9112389
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of [125I]VIP binding sites and effects of VIP on cAMP-formation in rat insulinoma (RINm5F and RIN14B) cells.
    Andersson M, Sillard R, Rökaeus A.
    Regul Pept; 1992 Jul 02; 40(1):41-9. PubMed ID: 1332138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.